Olema Pharmaceuticals Inc expected to post a loss of 73 cents a share - Earnings Preview

Olema Pharmaceuticals

05/08/2023 01:26

* Olema Pharmaceuticals Inc  OLMA.OQ   OLMA.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 7 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Olema
Pharmaceuticals Inc
is for a loss of 73 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Olema
Pharmaceuticals Inc is $17​, above​ its last closing price
of $9.36. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.71       -0.66      -0.70     Missed  -5.5
 Dec. 31 2023  -0.62       -0.65      -0.65     Met     0.3
 Sep. 30 2022  -0.76       -0.77      -0.57     Beat    25.8​
 Jun. 30 2022  -0.65       -0.64      -0.82     Missed  -27.7
 ​​Mar.        -0.61       -0.57      -0.58     Missed  -1.8
 31 2022                                                
 Dec. 31 2021  -0.50       -0.49      -0.54     Missed  -9.1​
 Sep. 30 2021  -0.44       -0.46      -0.45     Beat    1.3
 Jun. 30 2021  -0.38       -0.38      -0.42     Missed  -10.5
 This summary was machine generated August 5 at 00:26 GMT.  All
figures in US dollars  unless otherwise stated